| Mckenzie Morgan, LCSW | |
|
377 E Riverside Dr, Bldg B, St George, UT 84790-8013 | |
| (435) 229-9511 | |
| Not Available |
| Full Name | Mckenzie Morgan |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 377 E Riverside Dr, St George, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053959601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 11435466-3502 (Utah) | Secondary |
| 1041C0700X | Social Worker - Clinical | 11435466-3501 (Utah) | Primary |
| Entity Name | Therapy Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578703468 PECOS PAC ID: 3173882065 Enrollment ID: O20180123001292 |
News Archive
Home-based telemental health for depression is well received by patients and delivers as good a quality of life as in-person visits, according to the results of a clinical trial in 241 depressed elderly veterans reported in the Journal of Clinical Psychiatry by investigators at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center.
Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.
The underdevelopment of a specific region in the brain may lead to schizophrenia in individuals. According to research published today in BioMed Central's open access journal Molecular Brain, dentate gyrus, which is located in the hippocampus in the brain and thought to be responsible for working memory and mood regulation, remained immature in an animal model of schizophrenia.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mckenzie Morgan, LCSW 377 E Riverside Dr, Bldg B, St George, UT 84790-8013 Ph: (435) 229-9511 | Mckenzie Morgan, LCSW 377 E Riverside Dr, Bldg B, St George, UT 84790-8013 Ph: (435) 229-9511 |
News Archive
Home-based telemental health for depression is well received by patients and delivers as good a quality of life as in-person visits, according to the results of a clinical trial in 241 depressed elderly veterans reported in the Journal of Clinical Psychiatry by investigators at the Medical University of South Carolina and the Ralph H. Johnson VA Medical Center.
Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.
The underdevelopment of a specific region in the brain may lead to schizophrenia in individuals. According to research published today in BioMed Central's open access journal Molecular Brain, dentate gyrus, which is located in the hippocampus in the brain and thought to be responsible for working memory and mood regulation, remained immature in an animal model of schizophrenia.
The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.
› Verified 5 days ago